Regulatory Story
Go to market news section View chart   Print
RNS
Pets At Home Group Plc  -  PETS   

Preliminary Results FY18 to 29 March 2018

Released 07:00 22-May-2018

RNS Number : 7964O
Pets At Home Group Plc
22 May 2018
 

22 MAY 2018, THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

Pets at Home Group Plc: Preliminary Results FY18

for the 52 week period to 29 March 2018

Back on a stronger competitive footing

GBPm

FY17

FY18

Change

Group like-for-like revenue growth#

1.5%

5.5%


     Merchandise LFL#

0.8%

5.0%


     Services & other LFL#

7.9%

8.5%






Group revenue

834.2

898.9

7.8%

     Merchandise revenue

716.7

765.4

6.8%

     Services & other revenue

117.5

133.5

13.7%





Group gross margin

54.2%

51.7%

(249) bps

Underlying profit before taxa, #

96.4

84.5

(12.3)%

Statutory profit before tax

95.4

79.6

(16.6)%





Free cashflow#

64.6

55.8

(13.6)%

a.         Non-underlying items in FY18 include £2.7m associated with the closure of Barkers, £1.6m accounting charge for the acquisition of minority stakes owned by vet partners in Specialist Referral Centres, and £0.6m of other expenses. Non-underlying items in FY17 include £1.0m of expenses for the disposal of Farm Away Limited, the Group's equestrian retailing business.

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

·     Strong trading in Merchandise with FY18 like-for-like revenue# growth of 5.0% (Q4 LFL#: 7.5%) and market share gains in food and accessories

·     Omnichannel revenues# of £51.4m grew at 75.1%, ahead of the online pet market and key competitors

·     Total fee income from First Opinion Joint Venture vet practices up 16.1% to £53.1m and double digit revenue growth in Specialist Referral Centres

·     Group PBT position: reflects our c£13m price investment in Merchandise, which remains on track and is delivering positive results faster than expected, and a £5.0m increase in the provision held for practice loans in our veterinary business

·     Net openings completed: 13 superstores, 25 vet practices and 27 grooming salons. Closed seven Barkers stores as previously announced

·     Total dividend payable of 7.5 pence per share, maintained at the prior year level

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

 

Peter Pritchard, Group Chief Executive Officer, commented:

"I'm proud and excited to be taking over as CEO. The value of our business is much greater than being a retailer, or a vet care provider. It's the way we can give pet owners a breadth of products, grooming, vet care and other services. Combined with the way we can serve them through stores, the website and our pet professionals, the colleagues and vets who genuinely care about customers and their pets.

Our plans to reposition retail are working, more customers are coming back to shop with us, and we are committed to returning the business to profit growth. But it hasn't been easy. We took decisive action, threw passion and energy into it, and delivered targeted pricing changes to give customers the products that mattered most to them, with the service and value they expect from us. Our product innovation this year has been the best I can remember and the investment we made in the development of a subscription service is bringing some excellent results, as is Order In-Store, which brings our full online range to every store in the business.

The veterinary services market is a very attractive space in which we can grow. We have a profitable business delivering strong returns, achieved largely through our preference to work in partnership with vets who share in the success of their practice. The shortage of qualified vets in the UK remains an industry wide problem, so we have chosen to slow our practice rollout to be sure we open practices in quality locations for the best vet partners. With slower rollout we can, and need to, focus more on strategies to accelerate growth in our existing practices, where we know there is still huge potential. About 84%b of our First Opinion practices are relatively young and whilst they require more funding from us over the next 4-5 years, the long-term prize for us and our vet partners is substantial.

We have a bright future. Year one of our three-year strategy has delivered, and as a business we are on a stronger competitive footing to return to sustainable profit growth. But the job isn't done yet. As our new CEO, my plan has a bigger focus on digital, tapping into the vast potential of our customer and pet data, and taking action to ensure our vet business reaches its potential. Our market has a track record of resilience in a downturn and as we adapt to a changing environment, we will emphasise the things that make Pets at Home unique and best placed to serve the UK's pet loving owners."

b. Refers to vet practices younger than 10 years

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Outlook and guidance

The pet care market remains resilient, with growth in pet products estimated at c2% in 2017, and veterinary services at c5%. We again grew our market share in the vet segment and are pleased to say that following our price repositioning work in retail, we have won back share in the food and accessories markets.c

FY19 will be the second of our three year financial transition back to sustainable profit growth, and following our progress in FY18, we are determined to achieve our plan. In the coming financial year we are targeting like-for-like revenue growth ahead of the market in both Retail and our Vet Group, and a transition back to low single digit underlying Group profit# growth. We remain a cash generative business with a priority to invest in our core capabilities, particularly our Vet Group.

c. Market information sourced using internal data and UK pet market reports

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

FY19 guidance

·     Rollout: up to five superstores, 20-25 vet practices, 10-20 grooming salons

·     Group gross margin down (75-125) bps, reflecting the annualisation of last years price investment, mitigated by the growing margin of our vet business

·     Underlying operational cost# growth (excluding depreciation and amortisation) of 3-3.5%

·     Depreciation and amortisation £37-38m

·     Net interest £3-3.5m

·     Effective tax rate 20%

·     Capital investment £39-41m

·     Group working capital outflow of c£20m to support vet practice growth

·     Intention to maintain ordinary dividend payment at the prior year level

·     Non-underlying items: accounting treatment of the minority stakes owned by vet partners in the Specialist Referral Centres is likely to lead to a non cash operating expense charge of £1.5-2m. See page 12 for further detail

New financial reporting disclosure

In FY19 our financial reporting will change to two segments that better represent the size of the respective businesses and our internal reporting structures; Retail (includes products purchased online and in-store, pet sales and grooming services) and Vet Group (includes our First Opinion practices and Specialist Referral Centres). In order to familiarise readers of the accounts, and provide a basis for comparability, we show a pro-forma unaudited segmentation for the 52 weeks to 29 March 2018.

 

£m

Retail

 

Vet Group

Central costs

Total Group

LFL revenue growth #

4.6%

15.0%


5.5%

Revenue

804.9

94.1


898.9

Gross margin

52.2%

47.1%


51.7%

Underlying EBITDA#

97.3 d

31.9 e

(5.8)

123.3

Underlying EBIT#

65.1 d

29.6 e

(5.8)

88.8

 

d. Non-underlying items: £2.7m associated with the closure of Barkers

e. Non-underlying items: £1.6m accounting charge for the acquisition of minority stakes owned by vet partners in Specialist Referral centres, and £0.6m of other expenses

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Board appointments

Tessa Green, Independent Non-Executive Director, has decided to step down from the Board at the Annual General Meeting on 12 July 2018. Tessa will be succeeded by Professor Susan Dawson, Dean of the Institute of Veterinary Science at the University of Liverpool and council member of the Royal College of Veterinary Surgeons. Professor Dawson will Chair the Pets Before Profit and Corporate Social Responsibility Committees.

Results presentation

A presentation for analysts and investors will be held today at 10am at Goldman Sachs, River Court, 120 Fleet Street, London EC4A 2BE, attendance is by invitation only. An audio webcast and statement of these results will be available at http://investors.petsathome.com

Investor Relations Enquiries

Pets at Home Group Plc:                                                     +44 (0)161 486 6688

Amie Gramlick, Director of Investor Relations

Media Enquiries

Pets at Home Group Plc:                                                     +44 (0)161 486 6688

Brian Hudspith, Director of Corporate Affairs

Maitland:                                                                                +44 (0)20 7379 5151

James McFarlane, Joanna Davidson

About Pets at Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 448 superstores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 461 First Opinion practices located both in our stores and in standalone locations, as well as four Specialist Referral centres. For more information visit: http://investors.petsathome.com/

 

Disclaimer

This statement of preliminary financial results does not constitute an invitation to underwrite, subscribe for, or otherwise acquire or dispose of any Pets at Home Group Plc shares or other securities nor should it form the basis of or be relied on in connection with any contract or commitment whatsoever. It does not constitute a recommendation regarding any securities. Past performance, including the price at which the Company's securities have been bought or sold in the past, is no guide to future performance and persons needing advice should consult an independent financial adviser.

 

Certain statements in this statement of preliminary financial results constitute forward-looking statements. Any statement in this document that is not a statement of historical fact including, without limitation, those regarding the Company's future expectations, operations, financial performance, financial condition and business is a forward-looking statement. Such forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially. These risks and uncertainties include, among other factors, changing economic, financial, business or other market conditions. These and other factors could adversely affect the outcome and financial effects of the plans and events described in this statement. As a result you are cautioned not to place reliance on such forward-looking statements. Nothing in this statement should be construed as a profit forecast.

 

Chief Executive Officer's Review

Operational Highlights

ROLLOUT


FY17

FY18





Stores

Number of storesf

442

448

New superstores (net)

15

13





Vets

Number of vet practices (total)

436

461

Number of standalone vet practices

147

152

Number of in-store vet practices

289

309

New vet practices (net)

48

25





Groomers

Number of groomersf

290

309

New groomers (net)

50

27






% of stores with a vet practice & grooming salon

54%

58%





VIP CLUB





VIP Club active members (m) g

3.7

3.9


VIP swipe as % revenueh

68%

70%









PRODUCT





Proportion of product SKUs refreshed

39%

31%

f FY17 included seven Barkers stores with grooming salons, which have now closed

g Active defined as customers who have purchased during the past twelve months

h Average swipe rate of the card at store tills over latest quarterly period

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Strategic update

Drivers of our like-for-like growth

Home of all things pet

Our biggest competitive asset is the ability to give pet owners the full breadth of pet care; customers who shop across retail, grooming and vet have around three times the spend of those who are just retail customers.

Puppy owners are an opportunity to develop a relationship at one of the most important milestones - the first puppy shop. With that in mind, we gave a complete overhaul to our range and also launched the VIP Puppy Club. By joining the club, customers receive 10% off their first puppy product shop, a free bag of Advanced Nutrition food, their first month for free with a flea product subscription, a free puppy groom and a free vet nurse check. We have seen some great results from our initiative, where we have seen a 25% spending increase by Puppy Club customers.

Home of value and convenience

During the year, we invested c£13m in pricing to deliver better value for our customers. We have taken a targeted approach, which began with a campaign that lowered prices and highlighted the value in our private label Advanced Nutrition. This was followed by price adjustments across branded Advanced Nutrition, more food categories and pet essentials. We are confident this is driving a positive reaction with customers, having seen such a strong rebound in Merchandise trade during the year. Advanced Nutrition also performed very well, with 12.7% volume growth and significantly increased private label participation. Looking forward, maintaining a competitive price position will always be part of everyday strategy but this will not be to the same scale as the prior financial year.

Delivering better value for customers is also a priority in our grooming business, where we experienced some slower trading during the year. We are set to launch a trial package in selected salons where for an annual fee, customers can bring their dog for unlimited bath and brush treatments.

Whilst price has been an important part of our improved trading, it doesn't present the full story. Investing in digital helped deliver omnichannel revenue growth of 75%. The two initiatives driving such strong growth are order in-store, and subscription for flea products. We have also improved our website experience with a faster checkout process across mobile, tablet and desktop, and have started to trial repeat order across food products. Looking to the year ahead will see ongoing upgrades to our website look, content and navigation, with more subscription products in our plan.

Home of veterinary excellence

We have a successful veterinary business growing ahead of the market in both First Opinion practices and Specialist Referral Centres. The Vet Group generates cash returns on invested capital# of 24% despite the majority of practices (c84%b) being relatively young.

We can attribute the strong revenue growth in our First Opinion practices to a number of competitive differences; but also to the drive of our vet partners in the JV model, who share in the success of the practice. Our model provides vets with business services and cashflow support as they grow, in return for management fees.

The revenue progression for practices, and therefore our fee income, has been relatively consistent. In coming years, as our rollout profile swings more to standalone, rather than in-store practices, we may see some variations in revenue performance, although we still expect the standalone practices to deliver strong returns for the Group.

The path to profit growth for some practices is lengthening as a result of the upward pressure on payroll costs. This factor, combined with the large number of young practices in the business, is leading to increased funding requirements from Pets at Home in the form of working capital operating loans. We expect the overall funding level to continue to grow for the next 4-5 years, after which we expect to see the balance decline, and are comfortable this is mainly a feature of the immaturity of our estate.

With a long term view of growing our practices to maturity, the prize remains; for us in the mature profits from a mainly fixed cost business, and for our vet partners in the form of dividends and the capital value of their practice. We currently have 87 such practices that have fully repaid all debts and we are focusing more on strategies to accelerate growth in our existing practices, to ensure we can deliver the inherent potential of the business.

Retail space evolution and vet practice rollout

With a total of 448 superstores, our store estate is nearing its optimum size. In the coming year we will open only a small number of stores in carefully selected areas, in up to five new locations. At the same time, we will continue to rollout grooming salons amongst the existing store estate and expect to open 10-20.

In our veterinary business we opened a net number of 25 new practices to bring our total to 461. We also transformed more practices to give them extra consulting space, or longer opening hours, so that we have 10 'super surgeries' and six practices opening 24/7. The challenging supply of veterinarians has long been a feature of the UK market and was exacerbated after the Brexit vote (around 30% of vets in the UK are thought to be EU domiciled). In addition, our practice rollout has always been heavily weighted towards the end of our financial year, which has placed an excessive burden on the business and we are taking an active decision to spread this profile more evenly through the year. The supply of veterinarians is unlikely to change in the short term and our priority is to open practices in quality locations for the best vet partners. We expect to open 20-25 practices in the year ahead and have already opened four in the new financial year to date.

Strategic evolution in the year ahead

FY19 will be the second of our three year financial transition back to sustainable profit growth. Delivering the financial plan does not require adhering to our historical strategic priorities of growing like-for-like, space, and margins. Our strategy should evolve with the market and competitive changes, our challenges, and our ambitions.

Our immediate priorities are to address the few remaining areas of our price repositioning programme and taking action to ensure the vet business can deliver on its potential. But in the coming months, we will evolve our longer term strategic plan to become the best pet care business in the world; a bigger focus on digital, data, more services and changing the shape of our stores in an ongoing environment of channel shift. 

 

Peter Pritchard

Group Chief Executive Officer

22 May 2018

 

Chief Financial Officer's Review

The FY18 audited period represents the 52 weeks to 29 March 2018. The audited comparative period represents 52 weeks to 30 March 2017.

Financial Highlights

FINANCIALS

 

 

 

 

 


FY17

 

FY18

 

Change

 

Revenue

Revenue Split (£m)




Food

395.1

421.9

6.8%

Accessories

321.6

343.5

6.8%

Total Merchandise

716.7

765.4

6.8%

Services & othera

117.5

133.5

13.7%

Total Group

834.2

898.9

7.8%





Like-For-Like growth#

1.5%

5.5%


Merchandise LFL #

0.8%

5.0%


Services & other LFL #

7.9%

8.5%






Revenue Mix (% of total revenues)




Merchandise

85.9%

85.1%

(79) bps

Services & Other

14.1%

14.9%

79 bps






Gross Margin

Merchandise Gross Margin

57.6%

54.8%

(285) bps

Services & Other Gross Margin

33.3%

34.1%

78 bps

Total Gross Margin

54.2%

51.7%

(249) bps






EBITDA

Underlying EBITDAb, # (£m)

130.5

123.3

(5.6)%

Underlying EBITDA marginb, # 

15.6%

13.7%

(194) bps






Other

Income Statement

Underlying PBT b # (£m)

96.4

84.5

(12.3)%

Statutory PBT (£m)

95.4

79.6

(16.6)%

Underlying basic EPSb,# (p)

15.3

13.5

(11.2)%

Statutory basic EPS

15.1

12.6

(16.6)%

Dividend (p)

7.5

7.5

0%






Cashflow & Leverage

Free cashflow# (£m)

64.6

55.8

(13.6)%

CROIC#

20.6%

19.4%

(89) bps

Leverage (ND/ Underlying EBITDA) #

1.2x

1.1x


 

a. Includes veterinary Joint Venture fees & other veterinary income, specialist referrals revenue, grooming salon revenue, revenue from live pet sales & insurance

b. Non-underlying items in FY18 includes £2.7m associated with the closure of Barkers, £1.6m accounting charge for the acquisition of minority stakes owned by vet partners in specialist referral centres, and £0.6m of other expenses. Non-underlying items in FY17 includes £1.0m of expenses for the disposal of Farm Away Limited, the Group's equestrian retailing business.

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

 

Sales and revenue

Group revenue grew by 7.8% to £898.9m (FY17: £834.2m) and Group like-for-like revenues# (LFL) grew 5.5%.

Merchandise revenue, which includes food and accessories, grew by 6.8% to £765.4m (FY17: £716.7m), with LFL revenue# of 5.0%. This reflects particularly strong performance from our omnichannel business, which grew its revenues by 75.1% to £51.4m, but also from store sales, which grew by 3.9%. Food revenue grew by 6.8% to £421.9m (FY17: £395.1m), with strength across all areas of dog and cat food, including Advanced Nutrition, where revenue grew by 6.0% £189.8m (FY17: £179.1m).

Accessories revenue grew by 6.8% to £343.5m (FY17: £321.6m), where dog accessories and toys were a core driver, alongside subscription plans in licensed flea prevention products.

Services revenue grew by 13.7% to £133.5m (FY17: £117.5m), with LFL revenues# of 8.5%. We saw good growth across our Vet Group in both Specialist Referral Centres and also the First Opinion business, where practice income increased by 16.1% to £53.1m (FY17: £45.8m). Also within Services, our grooming salons experienced slower growth than in prior periods, and we also saw some weakness in trade from declining pet sales, which is an ongoing trend.

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Gross margin

Group gross margin declined by 249 bps to 51.7% (FY17: 54.2%).

Gross margin within Merchandise was 54.8%, a reduction of 285 bps over the prior year (FY17: 57.6%), in line with our plans. This mainly reflects our price repositioning activities of c£13m, a foreign currency impact of £5.7m from the movement in USD versus GBP and the growth of our omnichannel business, which has a greater mix of food product versus higher margin accessories.

Gross margin within Services increased by 78 bps to 34.1% (FY17: 33.3%). We saw expansion in the underlying gross margin of veterinary First Opinion practices and Specialist Referral Centres, but at an overall level, the First Opinion business saw a decline in gross margin due to a £5.0m increase in the provision held for practice operating loans. We also experienced a significant improvement in the margin of pet sales in store, which reflects our activities to improve and simplify the care and welfare routines. This benefit is expected to be a one-off feature of FY18.

Underlying EBITDA# and operating costs

Underlying EBITDA# was £123.3m (FY17: £130.5m), with a margin of 13.7% (FY17: 15.6%).

Selling and distribution (S&D) expenses of £309.5m decreased as a percentage of Group revenue, to 34.4% (FY17: 35.5%). Within this, we saw £2.5m in cost savings as a result of our energy saving programme, and occupation costs (rent, service charges and other costs) again declined as a percentage of sales as we benefit from the rent paid by vet practices in our stores, which contributed £11.7m (FY17: £10.7m). Colleague costs also declined as a percentage of sales, particularly in relation to stores, where we have reduced payroll hours by streamlining non customer facing activities.

Underlying administration expenses of £66.3m were 7.4% of revenue (FY17: 6.6%), where we are seeing growth in Vet Group operating costs, alongside our investment in business systems and omnichannel.

Non-underlying costs totaled £4.9m. Of this, £2.7m relates to the closure of our trial Barkers stores and the associated lease commitments and write down of fixed assets. In addition, £1.6m of non-underlying costs were recognised in relation to the ownership structures and accounting treatment of the veterinary Specialist Referral centres (see detailed note below on page 21.) There were also £0.6m of M&A related expenses, for transactions that were not completed.

Depreciation and amortisation, which is contained within our total operating costs, increased to £34.5m (FY17 £29.6m).

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Underlying finance expense

Underlying net finance expense# for the year was £4.3m (FY17: £4.5m).

Taxation, trading profit & EPS

Underlying pre tax profit# was £84.5m (FY17: £96.4m) and statutory pre tax profit, was £79.6m (FY17: £95.4m).

Underlying total tax expense# for the period was £17.0m, a rate of 20% on underlying pre tax profit#.

Underlying profit for the period#, after tax, was £67.5m (FY17: £76.3m) and underlying basic earnings per share# were 13.5 pence, (FY17: 15.3 pence). Statutory basic earnings per share were 12.6 pence (FY17: 15.1 pence).

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Working capital# and funding for vet practices

The cash movement in trading working capital# for FY18 was an inflow of £9.4m. This was comprised of a £4.1m increase in inventory, offset by a £3.9m decrease in receivables and a £9.6m increase in payables.

We increased our working capital support to First Opinion veterinary practices with £14.8m in operating loans. This created an overall increase in Group receivables of £10.9m and overall Group cash working capital outflow of £5.4m.

Operating loans represent cash funding we choose to provide to Joint Venture First Opinion veterinary practices, to assist with their working capital requirements and underpin their growth to maturity. The gross value of operating loans at the end of the financial year was £38.0m (FY17: £23.2m), against which a provision of £8.3m is held (FY17: £3.3m). The increased provision reflects both the longer maturity curves for practices, as well as an improvement in methodology used to assess the operating loan balance. A provision has been applied to all outstanding practice loan balances, which we believe is more appropriate considering the growing size of our First Opinion business.

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Capital investment

Capital investment was £40.7m (FY17: £44.5m), where £12.8m is represented by the refurbishment and retrofit of services into our existing store estate (FY17 £16.8m) and new store capital investment totalled £7.3m (FY17: £6.4m). Investment in business systems totalled £10.0m (FY17: £7.2m), and £2.3m was part of the energy savings programme to fit LED lighting and smart energy management systems in our store estate (FY17: £5.8m). Cash capital expenditure was £41.6m (FY17: £40.9m).

Cashflow and capital structure

Free cash flow (FCF) after interest, tax and before acquisitions# was £55.8m (FY17: £64.6m), representing a cash conversion rate of 45% (FY17: 49%). The decline in FCF when compared with the prior year is driven by our price investments in the Merchandise business, increased working capital requirements and the purchase of shares to satisfy colleague stock option schemes.

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Free cashflow # (£m)

FY17

FY18

Cash EBITDAc,#

133.0

127.2

Working capital#

(2.4)

(5.4)

Operating loans provision movement

0.1

5.0

Tax

(19.3)

(19.1)

Interest cost

(4.2)

(3.9)

Capital expenditure

(42.6)

(44.0)

Purchase of shares for colleague stock options

0.0

(4.0)

Reported free cashflow

64.6

55.8

c. Defined as underlying EBITDA plus IFRS2 share based payment charges

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

The Group's net debt position at the end of period was £135.2m, which represents a leverage ratio# of 1.1x underlying EBITDA.

 

£m

FY17

(53

FY18

(53

Opening net debt

(162.0)

153.7

Free cashflow#

64.6

55.8

Ordinary dividends paid

(39.9)

(37.3)

Acquisitions

(14.8)

0.0

Other

(1.6)

0.0

Closing net debt

(153.7)

(135.2)

Leverage (ND / underlying EBITDA#)

1.2x

1.1x

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Our capital structure and allocation policy remains as previously stated, with a priority to invest in areas that will expand the Group and deliver appropriate returns, particularly within our veterinary business. It is our intention to maintain a prudent approach to balance sheet management in the current economic environment, but retain some flexibility to increase leverage to an appropriate level in the event that suitable investment or acquisition opportunities arise. And dependent upon our acquisition outlook and if we do not foresee investment uses, it is our intention to return surplus free cashflow to shareholders.

Dividend

The Board has recommended a final dividend of 5.0 pence per share, giving a total dividend of 7.5 pence per share in respect of the 2018 financial year, equal with the prior year.

The final dividend will be proposed by the Directors at the 2018 AGM and is in addition to the interim dividend of 2.5 pence per share, paid to shareholders on the 12 January 2018. The ex-dividend date will be 14 June 2018 and, if approved at the Company's forthcoming AGM, will be paid to shareholders on 17 July 2018 to those shareholders on the register at the close of business on 15 June 2018.

Foreign exchange outlook

The Group purchases products from Asia to a value of around US$65 million each year.  Our policy is to use a mix of foreign exchange forward contracts to hedge our USD requirement for the next 12 months and up to 50% of the following 6 months.  The movement in hedged contract rates for FY18, which were at an average rate of 1.30 USD:GBP, created a £5.7m adverse cost to the Group.  The majority of our hedging requirement for FY19 is in place, at an average rate of 1.34 USD:GBP, which is expected to have a positive financial impact of around c£1 million.

Accounting treatment of veterinary Specialist Referral centres

Three of our four centres are structured as a Shared Venture ownership model, where Pets at Home maintains a minimum 75% controlling share, with the remaining shares owned by multiple clinician Shared Venture Partners (SVPs). Pets at Home has an option to buy the SVP shares in the future, with the value of these shares related to profit performance targets. The accounting treatment of such an option is therefore structured as a forward contract. Within the income statement, the discounted future value of the SVP's shares is recognised as an expense over the period to which the option can be exercised, and recognised as an non-underlying expense. We continue to expect this charge to be £1.5-2m for FY19.

New financial reporting disclosure

In FY19 our financial reporting will change to two segments that better represent the size of the respective businesses and our internal reporting structures; Retail (includes products purchased online and in-store, pet sales and grooming services) and Vet Group (includes our First Opinion practices both in-store and online, and Specialist Referral veterinary centres).

In order to familiarise readers of the accounts, and provide a basis for comparability, we show a proforma unaudited segmentation for the 52 weeks to 29 March 2018.

 

£m

Retail

 

Vet Group

Central costs

Total Group

LFL revenue growth #

4.6%

15.0%


5.5%

Revenue

804.9

94.1


898.9

Gross margin

52.2%

47.1%


51.7%

Underlying EBITDA#

97.3 d

31.9 e

(5.8)

123.3 3

Underlying EBIT#

65.1 d

29.6 e

(5.8)

88.8 3

 

d. Non-underlying items: £2.7m associated with the closure of Barkers

e. Non-underlying items: £1.6m accounting charge for the acquisition of minority stakes owned by vet partners in specialist referral centres, and £0.6m of other expenses

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

 

Mike Iddon

Chief Financial Officer

22 May 2018

 

 

Alternative Performance Measures ("APMs")

 

Guidelines on Alternative Performance Measures (APMs) issued by the European Securities and Markets Authority came into effect for all communications released on or after 3 July 2016 for issuers of securities on a regulated market.

In the reporting of financial information, the Directors have adopted various APMs of historical or future financial performance, position or cash flows other than those defined or specified under International Financial Reporting Standards (IFRS).

The Directors measure the performance of the Group based on the following financial measures which are not recognised under EU-adopted IFRS, and consider these to be important measures in evaluating the Group's strategic and financial performance. The Directors believe that these APMs assist in providing additional useful information on the underlying trends, performance and position of the Group.

APMs are also used to enhance the comparability of information between reporting periods, by adjusting for non-underlying items, to aid the user in understanding the Group's performance.

Consequently, APMs are used by the Directors and management for performance analysis, planning, reporting and incentive setting purposes and have remained consistent with prior year.

All APMs relate to the current period's results and comparative periods where provided.

 

The key APMs used by the Group are:

 

'Like-for-Like' sales growth comprises total revenue in a financial period compared to revenue achieved in a prior period, for stores, online operations, grooming salons, vet practices & Specialist Referral centres that have been trading for 52 weeks or more

 

Omnichannel revenue: revenue net of discounts and VAT from core online, sales, subscriptions and order to store.

 

EBITDA: Earnings before interest, tax, depreciation and amortisation before the effect of non-underlying items in the period.

 

Free Cash Flow: being net cash from operating activities, after tax, less net cash used in investing activities (excluding acquisitions), less interest paid and debt issue costs, and is stated before cash flows for non-underlying costs.

 

CROIC: Cash return on invested capital, represents cash returns divided by the average of gross capital (GCI) invested for the last twelve months. Cash returns represent pre-Non-underlying operating profit before property rentals and share based payments subject to tax then adjusted for depreciation and amortisation. GCI represents gross property, plant and equipment plus software and other intangibles excluding the goodwill created on the acquisition of the Group by KKR (£906,445,000) plus net working capital, plus capitalised rent multiplied by a factor of 8x.

 

Financial Statements

 

Financial Information

 

The financial information set out in this preliminary statement of annual results has been extracted from the Group's financial statements, which have been approved by a resolution of the Board of directors of the Company on 22 May 2018 and agreed with the Company's auditor. 

 

The financial information set out in this preliminary statement does not constitute the Company's statutory accounts for the year ended 29 March 2018 as defined in section 434 of the Companies Act 2006 (the "Act") which have not yet been delivered to the Registrar of Companies. 

 

The Company's auditor has reported on the FY18 financial statements.  Its reports were unqualified and did not draw attention to any matters by way of emphasis.  The reports also did not contain statements under section 498 of the Act.

 

 

Consolidated income statement

 

 


Note

 52 week period ended 29 March 2018

52 week period ended 30 March 2017

Underlying trading

£000

Total

£000

Underlying trading

£000

Non-underlying items (note 3)

£000

Total

£000

Revenue

2

898,924

-

898,924

834,169

-

834,169

Cost of sales


(434,316)

-

(434,316)

(382,287)

-

(382,287)

Gross profit


464,608

-

464,608

451,882

-

451,882

Selling and distribution expenses


(309,482)

-

(309,482)

(296,012)

-

(296,012)

Administrative expenses

3

(66,323)

(4,929)

(71,252)

(54,950)

(996)

(55,946)

Operating profit

2,3

88,803

(4,929)

83,874

100,920

(996)

99,924

Financial income

6

685

-

685

760

-

760

Financial expense

7

(4,963)

-

(4,963)

(5,300)

-

(5,300)

Net financing expense


(4,278)

-

(4,278)

(4,540)

-

(4,540)

Profit before tax


84,525

(4,929)

79,596

96,380

(996)

95,384

Taxation

8

(16,983)

201

(16,782)

(20,061)

41

(20,020)

Profit for the period


67,542

(4,728)

62,814

76,319

(955)

75,364

 

All activities relate to continuing operations.

Basic and diluted earnings per share attributable to equity shareholders of the Company:


Note

52 week period ended 29 March 2018

52 week period ended 30 March 2017

Equity holders of the parent - basic

5

12.6p

15.1p

Equity holders of the parent- diluted

5

12.5p

15.0p

 

Dividends paid and proposed are disclosed in note 9.

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Consolidated statement of comprehensive income

 


Note

52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017  

£000

Profit for the period


62,814

75,364

Other comprehensive income




Items that are or may be recycled subsequently into profit or loss:




Foreign exchange translation differences


71

(26)

Cash flow hedges - reclassified to profit and loss


(473)

(330)

Effective portion of changes in fair value of cash flow hedges


(1,695)

1,862

Other comprehensive income for the period, before income tax


(2,097)

1,506

Income tax on other comprehensive income


412

(297)

Other comprehensive income for the period, net of income tax


(1,685)

1,209

Total comprehensive income for the period


61,129

76,573

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Consolidated balance sheet

 


Note

At 29 March 2018 £000

At 30 March 2017 £000

Non-current assets




Property, plant and equipment


129,904

128,835

Intangible assets


992,929

990,266

Other non-current assets


20,182

16,990



1,143,015

1,136,091

Current assets




Inventories


60,529

56,420

Other financial assets


1,160

1,863

Trade and other receivables


74,848

69,567

Cash and cash equivalents


59,824

56,345



196,361

184,195

Total assets


1,339,376

1,320,286

Current liabilities




Trade and other payables


(173,856)

(165,887)

Corporation tax


(8,881)

(10,609)

Provisions


(835)

(492)

Other financial liabilities


(3,392)

(1,509)



(186,964)

(178,497)

Non-current liabilities




Other interest-bearing loans and borrowings

10

(194,519)

(209,296)

Other payables


(36,200)

(35,028)

Provisions


(2,200)

(1,394)

Other financial liabilities


(8,693)

(8,023)

Deferred tax liabilities


(4,448)

(5,404)



(246,060)

(259,145)

Total liabilities


(433,024)

(437,642)

Net assets


906,352

882,644

Equity attributable to equity holders of the parent




Ordinary share capital


5,000

5,000

Consolidation reserve


(372,026)

(372,026)

Merger reserve


113,321

113,321

Translation reserve


40

(31)

Cash flow hedging reserve


(950)

806

Retained earnings


1,160,967

1,135,574

Total equity


906,352

882,644

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

On behalf of the Board:

 

Mike Iddon Group Chief Financial Officer

Company number: 08885072

 

Consolidated statement of changes in equity as at 29 March 2018

 

 


Share capital

£000

Consolidation reserve

£000

Merger reserve

£000

Cash flow hedging reserve

£000

Translation reserve

£000

Retained earnings

£000

Total equity

£000

Balance at 30 March 2017

5,000

(372,026)

113,321

806

(31)

1,135,574

882,644

Total comprehensive income for the period








Profit for the period

-

-

-


-

62,814

62,814

Other comprehensive income

-

-

-

(1,756)

71

-

(1,685)

Total comprehensive income for the period

-

-

-

(1,756)

71

62,814

61,129

Transactions with owners, recorded directly in equity








Equity dividends paid

-

-

-

-

-

(37,341)

(37,341)

Share based payment charge






3,936

3,936

Purchase of own shares

-

-

-

-

-

(4,016)

(4,016)

Total contributions by and distributions to owners

-

-

-

-

-

(37,421)

(37,421)

Balance at 29 March 2018

5,000

(372,026)

113,321

(950)

40

1,160,967

906,352

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Consolidated statement of changes in equity as at 30 March 2017

 

 


Share capital

£000

Consolidation reserve

£000

Merger reserve

£000

Cash flow hedging reserve

£000

Translation reserve

£000

Retained earnings

£000

Total equity

£000

Balance at 31 March 2016

5,000

(372,026)

113,321

(429)

(5)

1,097,623

843,484

Total comprehensive income for the period








Profit for the period

-

-

-


-

75,364

75,364

Other comprehensive income

-

-

-

1,235

(26)

-

1,209

Total comprehensive income for the period

-

-

-

1,235

(26)

75,364

76,573

Transactions with owners, recorded directly in equity








Equity dividends paid

-

-

-

-

-

(39,850)

(39,850)

Share based payment charge

-

-

-

-

-

2,437

2,437

Total contributions by and distributions to owners

-

-

-

-

-

(37,413)

(37,413)

Balance at 30 March 2017

5,000

(372,026)

113,321

806

(31)

1,135,574

882,644

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Consolidated statement of cash flows

 


52 week period

ended

29 March 2018

£000

52 week period

ended

30 March 2017

£000

Cash flows from operating activities



Profit for the period

62,814

75,364

Adjustments for:



Depreciation and amortisation

34,483

29,621

Financial income

(685)

(760)

Financial expense

4,963

5,300

Loss on disposal of subsidiary

-

690

Loss/(profit) on disposal of property, plant & equipment

1,628

(176)

Share based payment charges

3,936

2,437

Taxation

16,782

20,020


123,921

132,496

Increase in trade and other receivables

(5,234)

(8,863)

Increase in inventories

(4,531)

(4,979)

Increase in trade and other payables

11,474

11,469

Increase in provisions

1,149

63


126,779

130,186

Tax paid

(19,054)

(19,299)

Net cash flow from operating activities

107,725

110,887

Cash flows from investing activities



Proceeds from sale of property, plant and equipment

814

1,830

Disposal of subsidiary, net of cash disposed

-

677

Interest received

685

722

Investment in other financial assets

(2,146)

(3,420)

Loans issued

(872)

(2,247)

Loans repaid

-

500

Acquisition of subsidiary, net of cash acquired

-

(14,831)

Acquisition of property, plant and equipment and other intangible assets

(41,613)

(40,896)

Net cash used in investing activities

(43,132)

(57,665)

Cash flows from financing activities



Equity dividends paid

(37,341)

(39,850)

Proceeds from new loan

-

8,000

Repayment of borrowings

(15,000)

-

Purchase of own shares

(4,016)

-

Finance lease obligations

(181)

(109)

Interest paid

(4,576)

(4,916)

Net cash used in financing activities

(61,114)

(36,875)

Net Increase in cash and cash equivalents

3,479

16,347

Cash and cash equivalents at beginning of period

56,345

39,998

Cash and cash equivalents at end of period

59,824

56,345

# Alternative Performance Measures (APMs) are defined & reconciled to IFRS, where possible

 

Notes

 

1 Basis of preparation

 

Pets at Home Group Plc (the Company) is a company incorporated in the United Kingdom and its registered office is Epsom Avenue, Stanley Green, Handforth, Cheshire, SK9 3RN.

The company is listed on the London Stock Exchange.

The consolidated financial statements for the 52 week period ended 29 March 2018 have been prepared in accordance with International Financial Reporting Standards as adopted by the EU (Adopted IFRS) and were approved by the Directors of the Company on 21st  May 2018 along with this preliminary announcement.

The consolidated financial statements are prepared on the historical costs basis except for derivative financial instruments, share based payments and certain investments measured at their fair value.

The financial information included in this preliminary statement of results does not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006 (the "Act"). The financial information for the 52 week period ended 29 March 2018 has been extracted from the statutory accounts on which an unqualified audit

opinion has been issued. Statutory accounts for the 52 week period ended 29 March 2018 will be delivered to the Registrar of Companies following the Company's Annual General Meeting.

The auditors have consented to the publication of the Preliminary Announcement as required by Listing Rule 9.7a having completed their procedures under APB bulletin 2008/2.

The directors of Pets at Home Group Plc, having made appropriate enquiries, consider that adequate resources exist for the Group to continue in operational existence for the foreseeable future and that, therefore, it is appropriate to adopt the going concern basis in preparing the consolidated financial statements for the 52 week period ended 29 March 2018.

 

2          Segmental reporting

 

The Directors consider there to be one operating and reportable segment, being that of the sale of pet products and services through retail outlets, specialist vet referral services and the Group's websites.

The Group's Board receives monthly financial information at this level and uses this information to monitor the performance of the store portfolio, allocate resources and make operational decisions. The internal reporting received focuses on the Group as a whole and does not identify other individual segments. To increase transparency, the Group has decided to include an additional voluntary disclosure analysing revenue within the reportable segment.

Revenue

52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Food

421,894

395,121

Accessories

343,508

321,550

Services and other

133,522

117,498


898,924

834,169

The 'services and other' category includes revenue from management fees for first opinion veterinary surgeries, veterinary services, grooming services, insurance commissions and the sale of pets.

The performance of the operating segment is primarily based on a measure of earnings before interest, tax, depreciation, and amortisation (EBITDA) before Non-underlying  items. This can be reconciled to statutory operating profit as follows:


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Operating profit

83,874

99,924

Non-underlying items

4,929

996

Underlying operating profit before Non-underlying items

88,803

100,920

Depreciation and amortisation

34,483

29,621

Underlying EBITDA

123,286

130,541

 

3     Expenses and auditor's remuneration

Included in operating profit are the following:


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Non-underlying operating expenses (see below)

4,929

996

Depreciation of tangible fixed assets

28,280

25,690

Amortisation of intangible assets

6,203

3,931

Rentals under operating leases:



Hire of plant and machinery

4,387

4,484

Property

75,922

73,002

Rental income from third party sublets

(1,041)

(828)

Rental income from related parties

(7,138)

(6,277)

Profit on disposal of fixed assets

-

(176)

Share based payment charges

3,936

2,437

 

Non-underlying items in operating profit in the 52 week period ended 29 March 2018 totalled £4,929,000 (2017: £996,000).  Of this, £2,685,000 relates to the closure of our seven trial Barkers stores, the associated lease commitments including disposal of fixed assets (£1,628,000).  Non-underlying operating expenses also includes £1,625,000 in relation to the increase in the fair value of the put and call option over the non-controlling interests in Dick White Referrals Limited, Eye-Vet Limited and Anderson Moores Veterinary Specialists Limited and £619,000 in relation to aborted property and acquisition costs.

Non-underlying items in operating profit in the period ended 30 March 2017 of £966,000 represent costs incurred in relation to the disposal of the Groups 100%  holding in Farm-Away Ltd.  The costs include legal and professional fees, redundancy costs and property costs.

The costs noted above are considered by the Directors to be non-underlying as they relate to either an event that is not expected to re-occur in future periods (as is the case with the closure of Barkers and disposal of Farm-Away), or the increase in the fair value of put/call liabilities which the Directors consider warrant separate disclosure due to the nature of these arrangements.

 

4     Colleague numbers and costs

The average number of persons employed (full time equivalents) by the Group (including Directors) during the period, analysed by category, was as follows:


52 week period ended 29 March 2018

Number

52 week period ended 30 March 2017

Number

Sales and distribution

6,142

6,152

Administration

559

659


6,701

6,811

 

The aggregate payroll costs of these persons were as follows:


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Wages and salaries

180,952

162,936

Social security costs

15,233

13,337

Contributions to defined pension contribution plans

5,725

5,251


201,910

 181,524

 

5     Earnings per share

Basic earnings per share is calculated by dividing the net profit for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.

Diluted earnings per share is calculated by dividing the net profit for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on the conversion of all dilutive potential ordinary shares into ordinary shares.


52 week period ended 29 March 2018

52 week period ended 30 March 2017

Underlying trading

After Non-underlying

items

Underlying

 trading

After Non-underlying

items

Profit attributable to equity shareholders of the parent (£000s)

67,542

62,814

76,319

75,364






Basic weighted average number of shares

500,000,000

500,000,000

500,000,000

500,000,000

Dilutive potential ordinary shares

3,119,537

3,119,537

4,032,406

4,032,406

Diluted weighted average number of shares

503,119,537

503,119,537

504,032,406

504,032,406






Basic earnings per share

13.5p

12.6p

15.3p

15.1p

Diluted earnings per share

13.4p

12.5p

15.1p

15.0p

 

6     Finance income


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Interest receivable

685

760

Total finance income

685

760

 

7     Finance expense


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Bank loans at effective interest rate

4,773

5,113

Other interest expense

190

187

Total finance expense

4,963

5,300

 

8     Taxation

Recognised in the income statement


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Current tax expense



Current period

17,837

20,953

Adjustments in respect of prior periods

(511)

(964)

Current tax expense

17,326

19,989

Deferred tax expense



Origination and reversal of temporary differences

(669)

(907)

Impact of difference between deferred and current tax rates

(260)

45

Adjustments in respect of prior periods

385

893

Deferred tax expense

(544)

31

Total tax expense

16,782

20,020

 

The UK corporation tax standard rate for the period was 19% (2017: 20%). The March 2016 budget announced a further reduction in the corporation tax rate to 17% from 1 April 2020. The deferred tax liability has been calculated based on the rate of 18% which is the blended rate at which items are expected to reverse.

Deferred tax recognised in comprehensive income


52 week period ended 29 March 2018

£000

52 week period ended 30 March 2017

£000

Effective portion of changes in fair value of cash flow hedges

(412)

297

 

Reconciliation of effective tax rate


52 week period ended 29 March 2018

52 week period ended 30 March 2017


Underlying trading £000

Non-underlying items £000

Total

£000

Underlying trading £000

Non-underlying items £000

Total

£000

Profit for the period

67,542

(4,728)

62,814

76,319

(955)

75,364

Total tax expense

16,983

(201)

16,782

20,061

(41)

20,020

Profit excluding taxation

84,525

 (4,929)

79,596

96,380

 (996)

95,384

Tax using the UK corporation tax rate for the period of 20% (53 week period ended 31 March 2016: 20%)

16,060

(937)

15,123

19,276

(199)

19,077

Impact of change in tax rate on deferred tax balances

(260)

-

(260)

45

-

45

Depreciation on expenditure not eligible for tax relief

588

-

588

706

-

706

Expenditure not eligible for tax relief

721

736

1,457

105

158

263

Adjustments in respect of prior periods

(126)

-

(126)

(71)

-

(71)

Total tax expense

16,983

 (201)

16,782

20,061

 (41)

20,020

 

The UK corporation tax standard rate for the 52 week period ended 29 March 2018 was 19% (52 week period ended 30 March 2017: 20%). The effective tax rate before Non-underlying items for the 52 week period ended 31 March 2018 was 20%. The principal reason for the difference in rate relates to the non-deductibility of depreciation charged on certain items of capital expenditure.

9     Dividends paid and proposed




52 week period ended

 29 March 2018

£000

52 week period ended

30 March 2017

£000

Declared and paid during the period



Final dividend of 5.5p per share (2017: 5.5p per share)

24,912

 

27,396

Interim dividend of 2.5p per share (2017: 2.5p per share)

12,429

12,454

Proposed for approval by shareholders at the AGM



Final dividend of 5.0p per share (2017: 5.0p per share)

24,836

24,912

The trustees of the following holdings of Pets at Home Group Plc shares under the Pets at Home Group Employee Benefit Trusts have waived or otherwise foregone any and all dividends paid in relation to the period ended 29 March 2018 and 30 March 2017 and to be paid at any time in the future (subject to the exceptions in the relevant trust deed) on its respective shares for the time being comprised in the Trust Funds: Computershare Nominees (Channel Islands) Limited (holding at 29 March 2018: 3,271,102 shares, holding at 30 March 2017: 1,319,091 shares) and Wealth Nominees Limited (holding at 29 March 2018: nil shares, holding at 30 March 2017: 434,056 shares).

10   Other interest-bearing loans and borrowings



At 29 March 2018 £000

At 30 March 2017 £000

Non-current liabilities



Secured bank loans

194,519

209,296

Total liabilities



Secured bank loans

194,519

209,296

 

Terms and debt repayment schedule


Currency

Nominal interest rate

Year of maturity

Face value at 29 March

2018

£000

Carrying amount at 29 March

2018

£000

Face value at 30 March

2017

£000

Carrying amount at 30 March

2017

£000

Senior Finance Bank Loans

GBP

LIBOR +1.25%

 2020

195,000

194,519

210,000

209,296

 

The Group's Senior Financing Facilities (as amended in April 2015) include a revolving credit facility (RCF) of £260m.  The RCF expires in April 2020 and is reviewed each period. Interest is charged at LIBOR plus a margin based on leverage (net debt: EBITDA). Face value represents the principal value of the Senior Finance Bank Loans. The bank loan is secured against the various tangible, intangible and monetary assets of the Group (excluding investments in joint ventures and hedging agreements).

Interest-bearing borrowings are recognised initially at fair value, being the principal value of the loan net of attributable transaction costs. Subsequent to initial recognition, interest-bearing borrowings are stated at a carrying value, which represents the amortised cost of the loans using the effective interest method less any impairment losses.

At 29 March 2018 the Group had a revolving credit facility of £260m with a drawn amount of £195m.

The analysis of repayments on the loans is as follows:


At 29 March 2018 £000

At 30 March 2017

£000

Within one year or repayable on demand

-

-

Between one and two years

-

-

Between two and five years

195,000

210,000


195,000

210,000

 

The combined loans at 29 March 2018 and 30 March 2017 are held by the Company.

Analysis of changes in net debt


At

30 March 2017 £000

Cash flow

£000

Non-cash movement

£000

At

29 March 2018 £000

Cash and cash equivalents

56,345

3,479

-

59,824

Debt due within one year at face value

-

-

-

-

Debt due after one year at face value

(210,000)

15,000

-

(195,000)

Net debt

(153,655)

18,479

-

(135,176)

 

Glossary - Alternative Performance Measures

 

Guidelines on Alternative Performance Measures (APMs) issued by the European Securities and Markets Authority came into effect for all communications released on or after 3 July 2016 for issuers of securities on a regulated market.

In the reporting of financial information, the Directors have adopted various APMs of historical or future financial performance, position or cash flows other than those defined or specified under International Financial Reporting Standards (IFRS).

The Directors measure the performance of the Group based on the following financial measures which are not recognised under EU-adopted IFRS, and consider these to be important measures in evaluating the Group's strategic and financial performance. The Directors believe that these APMs assist in providing additional useful information on the underlying trends, performance and position of the Group.

APMs are also used to enhance the comparability of information between reporting periods, by adjusting for non-underlying items, to aid the user in understanding the Group's performance.

Consequently, APMs are used by the Directors and management for performance analysis, planning, reporting and incentive setting purposes and have remained consistent with prior year.

All APMs relate to the current period's results and comparative periods where provided.

APM


Definition


Reconciliation

Cash EBITDA


Underlying EBITDA (see below) adjusted for share based payment charge.


Cash EBITDA (£m)

FY17

FY18

Note



Underlying EBITDA

130.5

123.3




Share based payment charge

2.4

3.9

3



Cash EBITDA

132.9

127.2


CROIC


Cash return on invested capital, represents cash returns divided by the average of gross capital (GCI) invested for the last twelve months. Cash returns represent underlying operating profit before property rentals and share based payments subject to tax then adjusted for depreciation and amortisation. GCI represents gross property, plant and equipment plus software and other intangibles excluding the goodwill created on the acquisition of the Group by KKR (£906,445,000) plus net working capital, plus capitalised rent multiplied by a factor of 8x.


CROIC

FY17

FY18

Note



Cash returns:






Underlying operating profit

100.9

88.8




Property rental costs

73

75.9

3



Share based payment charges

2.4

3.9

3




176.4

168.7




Effective tax rate

20%

20%




Tax charge on above

-35.3

-33.7





141.1

134.9




Depreciation and amortisation

29.6

34.5

3



Cash returns

170.7

169.4










Gross capital invested (GCI):






Gross property, plant and equipment

234.9

263.1




Intangibles

1,005.50

1,014.40




Less KKR goodwill

-906.5

-906.5




Investments

12.6

14.7




Net working capital

-87.4

-89.8

see definition



Capitalised operating leases

584

607.4

8x



GCI

843.1

903.3




Average

827.6

873.2




Cash returns/average CGI

20.60%

19.40%


Underlying EBITDA


Earnings before interest, tax, depreciation and amortisation before the effect of Non-underlying items in the period. This is a key management incentive metric.


Underlying EBITDA (£m)

FY17

FY18

Note



Statutory operating profit (audited)

99.9

83.9




Depreciation and amortisation

-29.6

-34.5

3



Non-underlying items

-1

-4.9

3



Underlying EBITDA

130.5

123.3


Free cash flow


Free cash flow being net cash from operating activities, after tax, less net cash used in investing activities (excluding acquisitions), less interest paid, debt issue costs, purchase of own shares and finance lease obligations, and is stated before cash flows for Non-underlying costs.


Free cash flow (£m)

FY17

FY18

Note



Free cash flow

64.6

55.8




Dividends

-39.9

-37.3

CFS



Acquisition of subsidiary

-14.8

-

CFS



Disposal of subsidiary

0.7

-

CFS



Loans issued

-2.2

-

CFS



Proceeds from new loan

8

-

CFS



Repayment of borrowings

-

-15

CFS



Net increase in cash

16.3

3.5




CFS = Consolidated Statement of Cash Flows

Gross profit margin (%)


Gross profit divided by revenue expressed as a percentage


Information provided in the consolidated income statement.

Like-for-like


'Like-for-like' sales growth comprises total revenue in a financial period compared to revenue achieved in a prior period, for stores, online operations, grooming salons, vet practices and referral centres that have been trading for 52 weeks or more


Not applicable.

Net debt


Cash and cash equivalents less loans and borrowings


A reconciliation of net debt is provided in note 10.

Underlying basic EPS


Underlying basic earnings per share (EPS) is based on earnings per share before the impact of certain costs or incomes that derive from events or transactions that fall outside the normal activities of the Group, and are excluded by virtue of their size and nature in order to reflect management's view of the performance of the Group.


Underlying basic EPS (p)

FY17

FY18

Note



Underlying basic EPS

15.3

13.5




Non-underlying items

-0.2

-0.9

5



Basic Earnings per share

15.1

12.6


Underlying operating profit


Underlying operating profit is based on operating profit before the impact of certain costs or incomes that derive from events or transactions that fall outside the normal activities of the Group, and are excluded by virtue of their size and nature in order to reflect management's view of the performance of the Group.


Underlying operating profit (£m)

FY17

FY18

Note



Underlying operating profit

100.9

88.8




Non-underlying items

-1

-4.9

3



Operating profit

99.9

83.9


Underlying profit before tax


Underlying profit before tax (PBT) is based on pre-tax profit before the impact of certain costs or incomes that derive from events or transactions that fall outside the normal activities of the Group, and are excluded by virtue of their size and nature in order to reflect management's view of the performance of the Group.


Underlying PBT (£m)

FY17

FY18

Note



Underlying PBT

96.4

84.5




Non-underlying items

-1

-4.9

3



PBT

95.4

79.6


Underlying profit after tax


Underlying profit after tax (PAT) is based on post tax profit before the impact of certain costs or incomes that derive from events or transactions that fall outside the normal activities of the Group, and are excluded by virtue of their size and nature in order to reflect management's view of the performance of the Group.


Underlying PAT (£m)

FY17

FY18

Note



Underlying PAT

76.3

67.5




Non-underlying items

-1

-4.9




PAT

75.4

62.6


Underlying total tax expense


Underlying total tax expense is based on the statutory tax expense for the period (being the net of current and deferred tax) before the impact of certain costs of incomes that derive from events or transactions that fall outside the normal activities of the Group, and are excluded by virtue of their size and nature in order to reflect management's view of the performance of the Group.


Underlying total tax expense (£m)

FY17

FY18

Note



Underlying tax expense

-20

-17




Non-underlying items

 -

0.2

3,8



Tax expense

-20

-16.8


Working capital


Working capital movement is a measure of the cash required by the business to fund its inventory, receivables and payables. The change year on year reflects the cash in/outflow in relation to changes in the working capital cycle excluding Non-underlying items. The change in working capital is a key component of the free cash flow measure of the Group.


Net working capital (£m) Movement

FY17

FY18

Note



Net working capital

-2.3

2.9




Being:






Increase in trade and other receivables

-8.9

-6

CFS



Increase in inventories

-5

-4.1

CFS



Increase in trade and other payables

11.5

11.8

CFS



Excluding movement in payables relating to Non-underlying items


-2.4




Decrease in provisions

0.1

1.1

CFS



Excluding movement in provision relating to


-0.9




Non-underlying items



Net working capital

-2.3

-0.4




CFS = Consolidated Statement of Cash Flows



Net working capital

FY17

FY18

Note



Receivables

69.7

74.8




Inventory

56.4

60.5




Trade and other receivables (incl Corporation Tax)

-211.6

-222.1




Provisions

-0.5

-0.8




Non-current provisions

-1.4

-2.2




Net working capital

-87.4

-89.8


Omni channel Revenue


Revenue net of discounts and VAT from core online, sales, subscriptions and order to store.


(£m)

FY17

FY18

Note






51.4

29.4


Underlying EBIT


Earnings before interest and tax  agreed to operating profit relating to underlying trading


 (£m)

FY17

FY18

Note



Operating profit relating to Underlying trading (EBIT)

100.9

88.8


 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR PGUGGAUPRPUG
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Preliminary Results FY18 to 29 March 2018 - RNS